Icares Medicus, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 08, 2019 at 12:23 am IST
Share
ICARES Medicus, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 108.097 million compared to TWD 79.052 million a year ago. Operating income was TWD 32.498 million compared to TWD 23.866 million a year ago. Net income was TWD 25.909 million compared to TWD 17.762 million a year ago. Basic earnings per share was TWD 0.78 compared to TWD 0.54 a year ago. Diluted earnings per share was TWD 0.77 compared to TWD 0.54 a year ago. For the nine months, sales was TWD 304.932 million compared to TWD 258.816 million a year ago. Operating income was TWD 79.304 million compared to TWD 81.590 million a year ago. Net income was TWD 62.904 million compared to TWD 63.157 million a year ago. Basic earnings per share was TWD 1.89 compared to TWD 2.04 a year ago. Diluted earnings per share was TWD 1.88 compared to TWD 2.02 a year ago.
Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.